← European Medicine Shortage Tracker · all medicines

Etoposid shortage — availability across Europe

Name: European Medicine Shortage Tracker dataset
Creator: MobiDoctor
License: https://creativecommons.org/licenses/by/4.0/

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Etoposid currently has availability issues reported in 2 European registers: Italy, Sweden.

Shortage ATC — · also listed as: étoposide · ETOPOSIDE · etoposid · data refreshed 9 September 2026

Key facts

As of 9 September 2026, Etoposid has active availability issues in 2 of 9 tracked European registers.
Registers reporting issues: Italy, Sweden.
Latest expected-resolution date on file: 2026-12-31.
Longest-running open report: since 2026-02-01 (7 months, Sweden).
Data source: 3 official medicines-agency registers, refreshed daily.

As of 9 September 2026, 2 of the 9 tracked registers list current availability issues for Etoposid, covering 4 affected product presentations. The longest-running open report was filed in Sweden on 2026-02-01 and has now been open for about 7 months. Where agencies state a cause, manufacturing problems lead with 2 of the 2 stated-cause reports. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-12-31. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇫🇷 France	Resolved Etopophos 100 mg, lyophilisat pour usage parentéral	—	2026-05-26	Hématologie, Oncologie/Radiothérapie	register ↗
🇮🇹 Italy	Shortage ETOPOSIDE SANDOZ + 1 more products ETOPOSIDE TEVA	2026-06-30	—	Problemi produttivi Alternatives: AIFA: equivalents with the same active substance are available.	register ↗
🇸🇪 Sweden	Shortage Eposin 20 mg/ml Koncentrat till infusionsvätska, lösning + 2 more products Etoposid Fresenius Kabi 20 mg/ml Koncentrat till infusionsvätska, lösning Etoposide Accord 20 mg/ml Koncentrat till infusionsvätska, lösning	2026-02-01	2026-12-31	— Alternatives: Alternative(s) available — see the national register.	register ↗

New register reports per month

Full report history (6 register entries)

Every individual register entry for Etoposid in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇸🇪 SE	Eposin 20 mg/ml Koncentrat till infusionsvätska, lösning	Discontinued	2027-08-31	—
🇮🇹 IT	ETOPOSIDE SANDOZ	Shortage	2026-11-02	—	Problemi produttivi
🇮🇹 IT	ETOPOSIDE TEVA	Shortage	2026-06-30	—	Problemi produttivi
🇸🇪 SE	Etoposide Accord 20 mg/ml Koncentrat till infusionsvätska, lösning	Shortage	2026-03-26	2026-08-31
🇸🇪 SE	Etoposid Fresenius Kabi 20 mg/ml Koncentrat till infusionsvätska, lösn	Shortage	2026-02-01	2026-12-31
🇫🇷 FR	Etopophos 100 mg, lyophilisat pour usage parentéral	Resolved	—	2026-05-26	Hématologie, Oncologie/Radiothérapie

Frequently asked

Is Etoposid currently in shortage in Europe?

Yes. As of 9 September 2026, availability issues are reported in: Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Etoposid shortage expected to end?

Agency prognoses on file range from 2026-12-31 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Etoposid?

4 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Etoposid availability data come from?

Directly from the official medicines-agency registers that list Etoposid: ANSM (France), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Etoposid — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/etoposid/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Etoposid availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/etoposid/">Etoposid shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Etoposid: availability status across 3 European registers — European Medicine Shortage Tracker (MobiDoctor), 9 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.